~~<i id='DFC597BBC4'><strike id='DFC597BBC4'><tt id='DFC597BBC4'><pre id='DFC597BBC4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

fashion

author：leisure time 2025-08-12 06:42:08 - browse：44259

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

entertainment

hotspot

focus

hotspot

SamuelCorum/GettyImagesTheDepartmentofJusticehasaskedafederaljudgetodismissalawsuitbroughtbyHumana,w

WSS

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Liver decline slowed by off

Addressing health care workers' trauma can help fight burnout

Study finds gene variants tied to breast cancer risk in Black women

Making the case for fair compensation in clinical trials

Wikipedia

fashion

entertainment

Novavax promises a turnaround & Lilly roils the obesity market

Study finds gene variants tied to breast cancer risk in Black women

Bright Health sells Medicare Advantage business to Molina

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

The high cost of giving birth even with insurance

SEC charges former device maker CEO with $41 million fraud

ChatGPT in medicine: STAT answers readers' burning questions

As a primary care physician, here's how I hope to partner with AI

hotspot

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Keeping primary care docs in field isn't impossible, says AAFP CEO

Questions and answers about ramping up H5N1 bird flu vaccine

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Fentanyl is making it harder to start addiction treatment

Cue Health, Covid

hotspot

focus

hotspot

hotspot